$TMK (Torchmark Corporation)

$TMK {{ '2015-12-04T15:33:35+0000' | timeago}} • SEC

During 3Q15, on S&P's formal operations and financial outlook review of $TMK, S&P revised its outlook from negative to stable and confirmed AA- ratings at $TMK's insurance subsidiaries and $TMK's senior debt "A" credit rating. $TMK does not expect that any changes to its capital position would impact its share repurchase program in future.

$TMK {{ '2017-05-19T11:10:20+0000' | timeago}} • Announcement

$TMK BoD declared a quarterly dividend of $0.15 per share on all of its outstanding common stock held of record as of the close of business on July 5, 2017.  The dividend will be paid on Aug. 1, 2017.

$TMK {{ '2017-04-20T16:44:44+0000' | timeago}} • Webcast

$TMK anticipates premium growth in the 1-3% range over the next few years at Liberty National. The company believes it will take a couple of years before the increase in sales translates into faster growth rates for this business.

$TMK {{ '2017-04-19T20:29:32+0000' | timeago}} • Announcement

For FY17, $TMK projects net operating income from continuing operations per share to be in the range of $4.63 to $4.77. During 1Q17, the company repurchased 1.1MM shares of its common stock at a total cost of $82MM for an average share price of $76.18.

$TMK {{ '2017-04-19T20:22:15+0000' | timeago}} • Announcement

Health insurer $TMK reported higher 1Q17 earnings, helped by higher revenue and net operating income. Net income for the quarter rose 7.66% to $133.5MM, or $1.11 per share from $124MM, or $1.01 per share a year ago. Total revenue rose 4.7% to $1,024MM. Net operating income from continuing operations rose 6.48% YoY to $1.15.

$TMK {{ '2017-03-01T13:45:24+0000' | timeago}} • Announcement

$TMK announced that its Board of Directors has raised the quarterly dividend to $0.15 per share on all of the outstanding common stock of the company held of record as of April 3, 2017. The dividend will be paid on May 1, 2017.

$TMK {{ '2017-02-01T23:01:01+0000' | timeago}} • Announcement

During 4Q16, $TMK repurchased 1MM shares of its common stock at a total cost of $71MM for an average share price of $68.60.

$TMK {{ '2017-02-01T22:59:41+0000' | timeago}} • Announcement

Health insurer $TMK 4Q16 net income rose to $135MM, or $1.12 per share, compared to $133MM, or $1.07 per share during 4Q15. Total revenues rose to $975MM from $934MM. Net operating income from continuing operations increased to $1.15 per share from $1.05 per share during 4Q15.

$TMK {{ '2016-11-14T11:34:27+0000' | timeago}} • Announcement

$TMK elected Steven Johnson to its BoD on Nov. 2, 2016. In addition, $TMK's BoD declared a quarterly dividend of $0.14 per common share, payable on Feb. 1, 2017 to shareholders of record on Jan. 6, 2017.

$TMK {{ '2016-10-26T23:49:11+0000' | timeago}} • Webcast

$TMK expects life insurance sales to be down 7-9% for 2016 and flat to down 5% for 2017.

$TMK {{ '2016-10-25T23:44:11+0000' | timeago}} • Announcement

$TMK narrowed its 2016 net operating income from continuing operations per share outlook to range of $4.43-4.49 from prior estimate of $4.40-4.50. The company projects 2017 net operating income from continuing operations of $4.55-4.85 per share.

$TMK {{ '2016-10-25T23:40:39+0000' | timeago}} • Announcement

Health insurance firm $TMK reported a rise in 3Q16 earnings driven by higher premium and a rise in net investment income. Net income rose to $152MM or $1.25 per share from $145MM or $1.15 per share last year. Total revenue grew to $990MM from $947MM. Net operating income from all operations per share increased to $1.18 from $1.08.

$TMK {{ '2016-09-08T22:52:52+0000' | timeago}} • Announcement

$TMK's BoD declared a quarterly dividend of $0.14 per share on all of the outstanding common stock of the company held of record as of the close of business on Oct. 7, 2016. The dividend will be paid on Nov. 1, 2016.

$TMK {{ '2016-07-28T23:15:58+0000' | timeago}} • Webcast

$TMK anticipates that the sale of its Medicare Part D business will generate approx. $20-25MM of additional capital to be available for 2016, plus an additional $55-60MM of additional capital that will be available in 2017. The company anticipates that certain investments that were downgraded by the NAIC in 1H16 will be upgraded by the end of 2017.

$TMK {{ '2016-07-28T23:13:28+0000' | timeago}} • Webcast

$TMK said it expects free cash flow in 2016 to be around $320MM. With $174MM spent on share repurchases thus far, the company expects to have around $146MM available for the remainder of 2016 from its free cash flow, plus other assets available at the parent.

$TMK {{ '2016-07-28T23:10:47+0000' | timeago}} • Webcast

$TMK said in 2Q16 Part D had a negative impact on excess investment income of approx. $2.5MM compared to negative impact of $2.3MM in the year ago quarter. For the full year 2016, the company expects excess investment income to grow by about 1-2%. On a per share basis, $TMK expects to see an increase of about 5-6%.

$TMK {{ '2016-07-28T23:08:14+0000' | timeago}} • Webcast

$TMK said on the health side, 2Q16 premium revenue grew 2% to $237MM, and health underwriting margin was also up 2% to $53MM. The company expects full year 2016 health underwriting margin to grow 1-2% from 2015. Health sales increased 6% to $33MM and individual health sales grew 8% to $30MM in 2Q16.

$TMK {{ '2016-07-28T23:06:39+0000' | timeago}} • Webcast

$TMK said in its life insurance operations, 2Q16 premium revenue grew 5% to $549MM, while life underwriting margin grew 3% to $144MM from a year ago. The company expects full year 2016 life underwriting margin to increase 1-2% over 2015. Net life sales were $110MM, up 2% from the year ago quarter.

$TMK {{ '2016-07-28T00:52:03+0000' | timeago}} • Announcement

For full-year 2016, $TMK expects net operating income from continuing operations per share to be in the range of $4.40-4.50. The company said that it has capital that is sufficient enough to support current operations.

$TMK {{ '2016-07-28T00:48:34+0000' | timeago}} • Announcement

During 2Q16, $TMK said that it repurchased 1.4MM shares of its common stock at a total cost of $83MM at an average share price of $57.77. For 1H16, the company stated that it repurchased 2.9MM shares at the average share price of $55.46.

$TMK {{ '2016-07-28T00:44:55+0000' | timeago}} • Announcement

Health insurance firm $TMK posted higher earnings in 2Q16 due to higher income before income taxes. Net income was $138MM or $1.13 per diluted share vs. $127MM or $1.00 per diluted share in 2Q15. Revenues rose 4.3% to $992MM vs. 2Q15, helped by higher premiums and net investment income in the quarter.

Recent Transcripts

BGCP (BGC Partners, Inc.)
Wednesday, July 26 2017 - 2:00pm
ANTM (Anthem, Inc.)
Wednesday, July 26 2017 - 12:30pm
BHLB (Berkshire Hills Bancorp Inc.)
Thursday, July 20 2017 - 2:00pm
SBNY (Signature Bank)
Wednesday, July 19 2017 - 2:00pm
MS (Morgan Stanley)
Wednesday, July 19 2017 - 12:30pm
BAC (Bank of America Corporation)
Tuesday, July 18 2017 - 12:30pm
C (Citigroup Inc.)
Friday, July 14 2017 - 3:30pm
JPM (JPMorgan Chase & Co.)
Friday, July 14 2017 - 12:30pm
AEG (AEGON N.V.)
Thursday, May 11 2017 - 7:00am
SLF (Sun Life Financial Inc.)
Wednesday, May 10 2017 - 5:00pm
PRI (Primerica, Inc.)
Wednesday, May 10 2017 - 2:00pm
AFSI (AmTrust Financial Services, Inc.)
Monday, May 8 2017 - 9:30pm
CI (Cigna Corp.)
Friday, May 5 2017 - 12:30pm
PRU (Prudential Financial, Inc.)
Thursday, May 4 2017 - 3:00pm
BGCP (BGC Partners, Inc.)
Thursday, May 4 2017 - 2:00pm
MFC (Manulife Financial Corporation)
Thursday, May 4 2017 - 12:00pm
MET (MetLife, Inc.)
Thursday, May 4 2017 - 12:00pm
ARCC (Ares Capital Corporation)
Wednesday, May 3 2017 - 4:00pm
VOYA (Voya Financial, Inc.)
Wednesday, May 3 2017 - 2:00pm
ALL (The Allstate Corporation)
Wednesday, May 3 2017 - 1:00pm

AlphaGraphics you may like